ESR(01821.HK)廊坊春暉產業園落成
ESR(01821.HK)公佈,華北ESR廊坊春暉產業園項目已於今年11月落成,樓高兩層,總規劃建築面積逾4.86萬平方米,位處於廊坊經濟技術開發區核心區域,目前開發區吸引全球23個國家及地區的6,000多家註冊企業進駐,當中包括電子信息、高端裝備製造、新材料和新能源、生命科學、現代物流、電子商務等現代產業體系。
公司表示,產業園按行業高標倉庫標準建設,整體採用鋼管混凝土結構體系,具抗風、抗地震能力。庫內無柱間支撐,空間可靈活運用,可滿足高端智能製造及供應鏈營運需求,項目屋頂更配備預冷太陽能電池板,體現低碳創新。
截至2022年6月30日,ESR在中國的總資產管理規模爲320億美元,建築面積約1,390萬平方米。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.